$1.56 Billion is the total value of Carlyle Group Inc.'s 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EVA | Enviva Partners LP | $356,425,000 | +1.7% | 11,155,725 | 0.0% | 22.90% | +31.5% | |
| WAIR | Wesco Aircraft Hldgs Inc | $254,297,000 | -0.8% | 23,096,882 | 0.0% | 16.34% | +28.3% | |
| CHK | Chesapeake Energy Corp | $243,785,000 | -27.7% | 172,897,387 | 0.0% | 15.67% | -6.5% | |
| ONE | Onesmart Intl Ed Group Ltdsponsored ads | $229,217,000 | -7.2% | 31,017,142 | 0.0% | 14.73% | +20.0% | |
| SMHI | Seacor Marine Hldgs Inc | $13,387,000 | -16.0% | 1,064,976 | 0.0% | 0.86% | +8.6% | |
| CIH | China Index Hldgs Ltdspnsrd ads a | $9,600,000 | +9.9% | 2,461,538 | 0.0% | 0.62% | +42.2% | |
| SQBG | Sequential Brnds Group Inc N | $1,414,000 | -59.6% | 6,369,812 | 0.0% | 0.09% | -47.7% | |
| SG | Sirius International Insuran | $1,414,000 | -28.8% | 174,170 | 0.0% | 0.09% | -8.1% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 25 | Q2 2024 | 1.7% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| ZoomInfo Technologies Inc | 17 | Q2 2024 | 61.4% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | May 13, 2024 | 193,195 | 4.1% |
| Q32 Bio Inc. | March 29, 2024 | 1,102,741 | 9.2% |
| HilleVax, Inc. | February 12, 2024 | 1,838,486 | 3.8% |
| Jasper Therapeutics, Inc. | February 12, 2024 | 1,066,189 | 7.1% |
| MKS INSTRUMENTS INCSold out | February 12, 2024 | 0 | 0.0% |
| Phathom Pharmaceuticals, Inc. | February 12, 2024 | 3,496,808 | 6.1% |
| ZoomInfo Technologies Inc. | February 12, 2024 | 35,244,474 | 9.0% |
| Adicet Bio, Inc. | February 07, 2024 | 3,060,292 | 4.1% |
| CommScope Holding Company, Inc. | January 03, 2024 | 42,257,593 | 16.6% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-09-10 |
| N-PX | 2024-08-30 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 4 | 2024-08-28 |
| 144 | 2024-08-23 |
| 144 | 2024-08-23 |
| 4 | 2024-08-13 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.